Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.
- DOI
- 10.1002/cncr.32383
- Published
- 2019 Nov 15
- Container
- Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cncr.32383,
title = {Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.},
author = {Khozin S and Miksad RA and Adami J and Boyd M and Brown NR and Gossai A and Kaganman I and Kuk D and Rockland JM and Pazdur R and Torres AZ and Zhi J and Abernethy AP},
year = {2019},
journal = {Cancer},
doi = {10.1002/cncr.32383},
url = {https://doi.org/10.1002/cncr.32383}
}RIS
TY - JOUR TI - Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer. AU - Khozin S AU - Miksad RA AU - Adami J AU - Boyd M AU - Brown NR AU - Gossai A AU - Kaganman I AU - Kuk D AU - Rockland JM AU - Pazdur R AU - Torres AZ AU - Zhi J AU - Abernethy AP PY - 2019 JO - Cancer DO - 10.1002/cncr.32383 UR - https://doi.org/10.1002/cncr.32383 ER -
APA
S, K., RA, M., J, A., M, B., NR, B., A, G., I, K., D, K., JM, R., R, P., AZ, T., J, Z., & AP, A. (2019). Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.. Cancer. https://doi.org/10.1002/cncr.32383
Source records
- pubmed · retrieved 2026-09-27T07:25:08.011Z